
At LogiPharma USA 2026, Cold Chain Technologies' TJ Rizzo explains how gaps in end-to-end cold chain expertise create risk for advanced therapies.
Wayne Rothman speaks about re-imagining the E2E value chain and delivering positive supply chains.
In an interview with Pharma Commerce Editor, Nicholas Saraceno, Wayne Rothman, VP, Value Chain Management, Johnson & Johnson, offers his thoughts on re-imaginging the end-to-end (E2E) value chain and delivering positive supply chains.






